Insider trade

Officer sold ~$720K of MRK shares in the open market

Traded Nov 3, 2025 · Filed Nov 4, 2025

MerckMRK

~$720K
Reported value · 8,614 sh @ $83.5895: 25K
Holds after · shares reported: +74.3%
stock since the trade · S&P 500 +11.8%, $82.49 → $143.81 on Oct 1

Why it stands out

Merck's Chief Info&Digital Officer sold $720K of Merck shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 3, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 4, 2025

Officer$500K–$1MPre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$720,040

Shares × reported transaction price

Timing vs results

4 days after results of Oct 30, 2025, 92 days before results of Feb 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $82.49 on Nov 3, 2025, 12% above its 52-week low and 21% below its high, after a 3% rise over the previous 30 trading days

52-week range $73.47 (May 14, 2025) to $103.79 (Dec 9, 2024), 30% of the way up, from 250 adjusted closes. 30 trading days earlier: $80.40 on Sep 22, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Feb 12, 2025 in the U.S. District Court, D. New Jersey. A filing is an allegation, not a finding.

IN RE MERCK & CO., INC. SECURITIES LITIGATION, docket 2:25-cv-01208, via CourtListener (court records). Nature of suit 850, company named as first defendant

FDA decision near the trade

FDA approved Winrevair on Oct 24, 2025, 10 days before this trade.

New use approved (efficacy supplement). Active ingredient: Sotatercept-Csrk. From openFDA. Dates only; no link between the two is implied

After it was reported

After	Stock	S&P 500	Difference
7 days	+8.4%	+0.9%	+7.5%
30 days	+18.2%	+1.2%	+17.0%
90 days	+37.3%	+1.8%	+35.5%
180 days	+34.0%	+6.0%	+28.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0000310158-25-000056
Filed / recorded: Nov 4, 2025, 9:02 PM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Merck & Co., Inc.
Issuer CIK: 310158
Ticker: MRK
Reporting person: David Michael Williams
Relationship: Officer
Officer title: EVP,Chief Info&Digital Officer
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Nov 3, 2025
Transaction code: S
Shares / units: 8,614
Price per share: $83.5895
Acquired / disposed: Disposed (D)
Shares owned after: 24,578.031
Ownership form: Direct
Amendment: No

Footnotes from the filing

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.5400 to $83.6200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.

Around the same time

Officer sold11mo ago

~$616KReported value · 7,085 sh @ $87.00

Merck's Chief Comm. & Public Afrs Ofcr sold $616K of Merck shares. Nobody planned it ahead of time.

Why it stands out Official record

12mo ago

Congress trade

$1,001 - $15,000Reported range · official band, not an exact amount

6 different filers disclosed MRK within 90 days. Disclosed 17 days after the transaction; reported as an official range, not an exact amount.

Why it stands out Official record

1y ago

Congress trade

$15,001 - $50,000Reported range · official band, not an exact amount

12 different filers disclosed MRK within 90 days. Disclosed 200 days after the transaction; reported as an official range, not an exact amount.

Why it stands out Official record